Skip to main content
Download PDF

Association between low eosinophil count and acute bacterial infection, a prospective study in hospitalized older adults

BMC Geriatrics volume 23, Article number: 852 (2023) Cite this article

Abstract

Background

The incidence of sepsis increases significantly with age, including a high incidence of bacterial infection in the old adults. Eosinopenia and the CIBLE score have been proposed in critically ill adults and in internal medicine wards. This study aimed to assess whether a low eosinophil count was associated with acute bacterial infection among hospitalized older adults, and to find the most efficient eosinophil count cut-off to differentiate acute bacterial infection from other inflammatory states.

Methods

This was a prospective study from July 2020 to July 2022 in geriatric wards of the University Paul Brousse Hospital (Villejuif, France) including patients aged of 75 y/o or over suffering from fever or biological inflammation. Acute bacterial infection was assessed using biological identification and/or clinical and radiological data.

Results

A total of 156 patients were included. Eighty-two (53%) patients suffered from acute bacterial infection (mean age (SD) 88.7 (5.9)). Low eosinophil count was independently associated with acute bacterial infection: OR [CI95%] 3.03 [1.04–9.37] and 6.08 [2.42–16.5] for eosinophil count 0–0.07 G/L and 0.07–0.172 G/L respectively (vs. eosinophil count > 0.172 G/L). Specificity and sensitivity for eosinophil count < 0.01 G/L and CIBLE score were 84%-49% and 72%-62%, respectively with equivalent AUCs (0.66 and 0.67).

Conclusion

Eosinophil count < 0.01 G/L is a simple, routinely used and inexpensive tool which can easily participate in antibiotic decisions for older adults. Further studies are needed to assess clinical benefits.

Trial registration

The study was registered at Clinical trial.gov (NCT04363138–23/04/2020).

Peer Review reports

Introduction

The incidence of sepsis increases significantly with age: less than 5/1000 when aged from 50 to 54 years old (y/o) vs. more than 25/1000 when aged 85 y/o and older [1]. Moreover, incidence of bacterial infection also increases with age: in the old adults: 1425.51/100 000 person-year, on 550 432 subjects over 4 years [2].

Diagnosis of acute bacterial infectious diseases can be challenging in hospitalized older adults. Indeed, atypical clinical presentations, such as the absence of fever, may occur in well documented infections in 20–30% of patients [3]. Furthermore, pathogens are distinct from those in younger patients with a high prevalence of hospital acquired infections [4,5,6,7,8]. Finally, commonly accepted biological markers (procalcitonin (PCT) or C reactive protein (CRP)) do not perform as accurately in older adults for bacterial infection diagnosis [9,10,11,12]. Thus, without bacterial documentation, no unique biological test can conclude to a bacterial infection [13, 14]. Other biological markers would be useful for diagnosing bacterial infection as antibiotic adverse events in older adults are more frequent and severe (such as delirium, falls and Clostridium difficile infection) [15]. It has been suggested that eosinopenia may occur during acute infection as a result of specific chemotactic agents being released [16].

In fact, a cohort study of 138 patients (mean age (standard deviation): 71.8 (20.8) y/o), eosinophil count < 0.04 G/L when the white blood cell count (WBC) was > 10 G/L showed a specificity of 100% and a sensitivity of 64% [17] for bacterial infections. Furthermore, a composite score (CIBLE score) that includes age, CRP, temperature, chronic obstructive pulmonary disease (COPD) and eosinophils/granulocytes count ratio, was found to predict bacterial infection when > 87, with a 72% sensitivity and a 77% specificity (190 patients, 73.5 (18.2) y/o) [18]. Thus eosinophil count drop, described in other inflammatory states because of eosinophil migration to tissue [19], may also be a marker of acute bacterial infection in older adults.

The goal of this study was to assess whether a low eosinophil count was associated with acute bacterial infection among old adults suffering from fever or inflammation. The secondary objective was to find the eosinophil count cutoff that most effectively differentiate acute bacterial infection from other inflammatory states.

Methods

Study design

This is a prospective study from July 2020 to July 2022 in the geriatric acute and rehabilitation wards of Paul Brousse University. The study was approved by an independent ethics committee (Comité de protection des personnes Sud Est V, Grenoble, France: 0-GERO-01, 05/14/2020) and was supported by Gérond’if (Gérontopôle d’Ile de France) (N°IDRCB 2020-A00301-38). All included participants were informed and did not oppose to the study as recommended by French ethics authorities. The study was registered at Clinical trial.gov (NCT04363138) and follows STROBE recommendations (additional file 1).

Inclusion criteria were age ≥ 75 years and fever defined by temperature ≥ 38 °C or biological inflammation: WBC > 10 G/L and CRP > 20 mg/L [18]. Non-inclusion criteria were patients under legal protection or already included in another protocol, patients suffering from any pathologies and treatments known to modify eosinophil cell count (asthma, human immunodeficiency virus infection, malignant hematologic diseases, parasite infection, stroke occurring less than one month before inclusion [20], eosinophilic granulomatous vasculitis, corticosteroid treatment, chemotherapy/immunosuppressive treatments, antibiotics less than one week before inclusion, SARS-CoV-2 infection [21]). Patients suffering from asymptomatic bacteriuria were also excluded. Patients were included only once if they had several fever or biological inflammation episodes during their hospitalization.

Patients

The following clinical characteristics were collected : age, sex, Charlson comorbidity index (0–29; a score > 4 predicts a one-year mortality risk of 85%) [22], chronic kidney failure defined by a Glomerular Filtration Rate (GFR) < 50 mL/min estimated by CKD-EPI equation [23], severe malnutrition (defined as a BMI < 20 kg/m2, ≥ 10% weight loss in a month or ≥ 15% weight loss in 6 months or ≥ 15% of the usual weight before the onset of the disease or serum albumin < 30 g/L) [24], polypharmacy (defined by ≥ 5 treatments), disability assessed by the Activity of Daily Life (ADL) scale (score 0–6, the higher the better) [25], and cognitive function assessed by the Mini Mental State Examination (MMSE) (score 0–30, the higher the better) [26]. Other frequent comorbidities were recorded: major depressive disorder according to DSM-5, hip fracture, atrial fibrillation and treated hypothyroidism.

The following biological data were collected WBC count (laboratory standards: 4–10 G/L), hemoglobin level (13–17 g/dL) and platelet count (150–450 G/L), CRP (< 4 mg/L), serum albumin level (32–46 g/L). Procalcitonin was not available on routine care. Blood count was analyzed by robot Sysmex-XN 1500 and data were collected from medical records.

Primary outcome

The primary outcome was to compare eosinophil count between two groups: patients with acute bacterial infection and patients without bacterial infection.

Diagnoses of acute bacterial infection were made according to the French Society of Infectious Diseases based on clinical symptoms, imaging data, and microbiological identification such as blood culture, urinalysis and urine culture, polymerase chain reaction (PCR), or stool culture.

Pneumonia diagnosis was based on a physical examination (dyspnea, peripheral oxygen saturation < 95%, or productive cough, with abnormal breath sounds at examination) and radiological confirmation (infiltrate at chest X-ray) if clinical examination was doubtful [27]. Urinary tract infection diagnosis was based on urinary symptoms (frequent urination, dysuria, lower back pain, abdominal pain) and bacteriological confirmation: pyuria > 104/mL with urinary bacterial count > 103 UFC/mL); cholangitis diagnosis was based on physical examination, abnormal liver function test and imaging (abdominal ultrasound or CT scan); diverticulitis diagnosis was based on physical examination and abdominal CT scan; osteitis diagnosis was based on physical examination and CT scan; bacteremia was defined by a positive blood culture.

Inflammation not related to bacterial infections included viral, neoplastic, and other inflammation. Viral infections were diagnosed by PCR (upper respiratory tract sample, cerebrospinal fluid sample). Neoplastic diagnosis was based on physical, radiological and cytopathology confirmation. All other pathologies with biological inflammation diagnosis were based on examination and imaging data.

Secondary outcome

Sensitivity, specificity and AUC (area under the curve) on bacterial diagnosis of several eosinophil counts cutoff were compared: < 0.04 G/L [28], < 0.01 G/L [17, 29] and eosinophil*1000/neutrophil count < 4 compared to CIBLE score > 87.

Statistical analysis

A total of 156 subjects needed to be included as calculated with the following parameters: sensitivity 72%, specificity 77%, delta of 0.12, and prevalence of 65%, based on the Bouldoires’ study [18].

Participants’ data are presented as mean and standard deviation (SD) for continuous variables and count (percentage) for categorical variables. T-tests were used for continuous variables and chi-squared tests or Fisher’s exact tests were used for categorical variables. The p-values were included for information purposes, only to assess the importance of any difference. Missing values and their distribution in the 2 groups were assessed. Because missing values represented < 2% of the data and were balanced between the 2 cohorts, no specific strategy was necessary. A stepwise multivariate analysis was performed to assess independent variables associated with bacterial infection diagnosis. To avoid overestimation, a conservative approach was used: all variables with p < 0.10 on univariate analysis and all clinically relevant variables from the literature were included. Eosinophil count was transformed to an ordered qualitative variable according to quartiles. Finally, Delong’s tests were used out to compare the areas under the curve (AUCs) of the different values studied.

Results

Population description

One hundred fifty-six patients were included between July 2020 and July 2022 (additional file 2). Eighty-two (53%) patients suffered from acute bacterial infection (mean age (SD) 88.7 (5.9) years old). The mean ADL and mean Charlson comorbidity score were respectively 3.8 (2.3) in the bacterial infection group vs. 3.8 (2.2) in the other group (p = 0.96) and 4.5 (3.1) vs. 4 [3] (p = 0.27) respectively. Results are summarized in Table 1 and detailed comorbidities and treatments are summarized in additional files 3 and 4.

Table 1 Patients characteristics according to bacterial infection diagnosis
Full size table

Main diagnosis

Overall, 112 (72%) patients were included because of biological inflammation and 88 (56%) because of fever, 45 (29%) patients because of both. In the acute bacterial infection group, 30 (37%) patients suffered from pulmonary infection including COPD exacerbation and 20 (24%) from urinary tract infection (Fig. 1). Of the 82 acute bacterial infections, 40 had pathogen identification, 24 diagnoses were made using clinico-radiological data and 18 on clinical argument alone. Details of pathogens and sites are provided in additional file 3. In the non-bacterial inflammation group, 34 (44%) patients suffered from inflammatory conditions (thrombosis, chondrocalcinosis, myocardial infarction, vascularitis), 11 (14%) from viral infections and 11 (14%) from neoplasm. For 6 (8%) patients, no diagnosis was found: elevated CRP or fever of unknown origin.

Fig. 1
figure 1

Histogram of infection sites in the acute bacterial infection group. Legends: L, Lungs; UT, Urinary Tract; B, Bacteriemia; BT, Biliary Tract; O, Osteitis/Spondylodiscitis; GI, Gastrointestinal; C, Cutaneous

Full size image

Eosinophil count association with acute bacterial Infection

The mean eosinophil count was 0.1 (0.2) G/L, 0.1 (0.1) G/L and 0.2 (0.2) G/L in the acute bacterial group and non-bacterial diagnosis group respectively (p < 0.001). Eosinophil count < 0.04 G/L, eosinophil count < 0.01 G/L and eosinophil/neutrophil count < 4 were more frequent in the acute bacterial group than in the non-bacterial diagnosis group (56.1% vs. 25.7%, p < 0.001; 48.8% vs. 16.2%, p < 0.001; and 52.4% vs. 21.6%, p < 0.001 respectively). Biological data are presented in Table 2.

A CIBLE score > 87 was more frequent in group 1 vs. group 2 (62.2% vs. 28.4%, p < 0.001).

Table 2 Patients’ biological characteristics and CIBLE score > 87 according to acute bacterial infection diagnosis
Full size table

In multivariate analysis, eosinophil count (ref: > 0.172 G/L) was independently associated with bacterial diagnosis: eosinophil count (0.07–0.172) OR 6.08 [2.42–16.5], (0–0.07) OR 3.03 [1.04–9.37] (Table 3).

Table 3 Logistic regression of bacterial diagnosis as dependent variable
Full size table

Eosinophil count < 0.01 G/L had the best specificity compared to the CIBLE score > 87 (84% vs. 72%) but a lower sensitivity (49% vs. 62%) with a comparable AUC (0.67 vs. 0.66; p = 0.87). All areas under the curve (AUC), sensitivities and specificities are presented in Table 4.

Table 4 Area under the curve (AUC), sensitivity and specificity of the biological variables associated with acute bacterial infections
Full size table

Discussion

This study shows that a low eosinophil count is independently associated with acute bacterial infection among hospitalized older adults: OR 3.03 [1.04–9.37] for eosinophil count 0–0.07 G/L compared to eosinophil count > 0.172 G/L. Eosinophil count < 0.01 G/L had better specificity (84%) than CIBLE score > 87, eosinophil count < 0.04 G/L, eosinophil/neutrophil ratio and CRP 72%, 74%78% and 49% respectively. While using both CIBLE score > 87 and eosinophil together improved specificity (89%), it did not improve AUC and decreased sensitivity (43%), at the coast of complicating the use in routine practice. Although the sensitivity of eosinophil count < 0.01 G/L was the lowest (49%), comparable AUCs were observed except for CRP, for which it was the lowest.

This result correlates with a prospective study (96 patients, mean age (SD): 64 [21] years old)), in which patients suffering from bacterial infection with eosinophil count < 0.01 G/L had a faster eosinophil normalization than CRP [19]. More recently, a retrospective study including 197 patients of an age closer to that ouf our study (mean age (SD): 89.6 (5.7)), found that persistent eosinophil count < 0.1 G/L between day 2 and day 4, was associated with in-hospital mortality (HR: 8.9 [3.46–22.9]) [30]. However, eosinophil count < 0.04 G/L combined with WBC > 10 G/L has been studied in an internal medicine ward on 138 patients aged of 71.8 (29.9) y/o, and had high specificity (100%) with a sensitivity of 64% [17].This result was not confirmed in our study, probably because WBC > 10 G/L and a CRP > 20 mg were inclusion criteria and included patients were older (88.8 (5.6) y/o compared to 71.8 y/o). This may be significant as inflammatory response changes with the ageing process [31]. Moreover, a meta-analysis [28] showed that a threshold of 0.02 G/L had better specificity for sepsis diagnosis (0.83 (0.80–0.85)) than a threshold of 0.04 G/L (0.75 (0.69–0.80)). However, like our study, this meta-analysis found low sensitivities. This is relevant because a low eosinophil count (e.g. < 0.01 G/L) may not be useful as a positive diagnosis marker but rather as a tool to exclude bacterial infection diagnosis.

To our knowledge, no study provided biological hypothesis to explain low eosinophil count specificity to acute bacterial infections. However, it may be partly explained by high recruitment in the tissues, secondary to chemoattractant released. Indeed, after being recruited, they improve membrane permeability allowing passage for other immune cells [32].

We acknowledge that this study has some limitations. First, it takes into account only one eosinophil dosage which has been shown to vary rapidly during the day [33]. However, as this is a prospective study, the biological samples were taken during standard care. Thus, they were routinely done at the same time and/or under the same circumstances. Second, some data are missing, mainly MMSE score, but to our knowledge, no relationship between cognitive disorders and low eosinophil count has been reported. Third, while COPD is a frequent pathology among the old adults (47.7% in the 75–80 y/o) [34], only 17 (10.9%) subjects with COPD were included. This may explain the lower specificity of the CIBLE score > 87. However, as corticosteroid therapy is a frequent COPD treatment and is known to alter eosinophil count [35, 36], this would have biased the results.

Nonetheless, to the best of our knowledge, this is first prospective study to evaluate eosinophil count as a marker for acute bacterial infection in hospitalized old adults.

Overall, we found that the use of eosinophil count < 0.01 G/L, along with other clinical and biological parameters, can be of interest to postpone antibiotic treatments and further investigations. This result is not intended to be used as diagnosis tool nor to replace gold standard. However, compared to the CIBLE score or other scores that need specific calculation tools, this is a daily routine exam and may be used to avoid over prescription and iatrogenic effects in this population [37, 38].

Conclusion

In this prospective monocentric study, conducted on 156 older inpatients in geriatric departments, a low eosinophil count was independently associated with the diagnosis of acute bacterial infection. Eosinophil < 0.01 G/L is a simple, routinely used and inexpensive tool that can easily participate in the medical decision to postpone antibiotic treatment. Further studies are needed to assess the clinical benefits in a larger population.

Data Availability

The datasets used and analyzed during the current study are available from the corresponding author on reasonable request.

Abbreviations

ADL:

Activity of Daily Life

AUC:

Area Under the Curve

BMI:

Body Mass Index

CRP:

C-reactive protein

GFR:

Glomerular Filtration Rate

MMSE:

Mini Mental Status Examination

PCR:

Polymerase Chain Reaction

PCT:

Procalcitonin

WBC:

White blood cells

References

  1. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med Juill. 2001;29(7):1303.

    Article  CAS  Google Scholar 

  2. Du WY, Yin CN, Wang HT, Li ZW, Wang WJ, Xue FZ et al. Infectious Diseases among elderly persons: results from a population-based observational study in Shandong province, China, 2013–2017. J Glob Health. 11:08010.

  3. Norman DC, Yoshikawa TT. Fever in the elderly. Infect Dis Clin North Am mars. 1996;10(1):93–9.

    Article  CAS  Google Scholar 

  4. Ravin KA, Loy M. The Eosinophil in Infection. Clin Rev Allergy Immunol avr. 2016;50(2):214–27.

    Article  CAS  Google Scholar 

  5. Yoshikawa TT. Epidemiology and unique aspects of aging and infectious Diseases. Clin Infect Dis off Publ Infect Dis Soc Am juin. 2000;30(6):931–3.

    Article  CAS  Google Scholar 

  6. Choi C. Bacterial Meningitis in aging adults. Clin Infect Dis off Publ Infect Dis Soc Am 15 oct. 2001;33(8):1380–5.

    Article  CAS  Google Scholar 

  7. Stocks G, Janssen HF. Infection in patients after implantation of an orthopedic device. ASAIO J Am Soc Artif Intern Organs 1992. 2000;46(6):41–6.

    Article  Google Scholar 

  8. Marrie TJ. Community-acquired Pneumonia in the elderly. Clin Infect Dis off Publ Infect Dis Soc Am oct. 2000;31(4):1066–78.

    Article  CAS  Google Scholar 

  9. Chassagne P, Perol MB, Doucet J, Trivalle C, Ménard JF, Manchon ND. Is presentation of bacteremia in the elderly the same as in younger patients? Am J Med. Jan; 1996;100(1):65–70.

    Article  CAS  PubMed  Google Scholar 

  10. Norman DC, Toledo SD. Infections in elderly persons. An altered clinical presentation. Clin Geriatr Med. (v; 1992;8(4):713–9.

    Article  CAS  PubMed  Google Scholar 

  11. Yan L, Liao P, Xu LL, Zhao Y. Usefulness of procalcitonin in elderly patients with bacterial Infection. Clin Lab. 2014;60(1):139–42.

    PubMed  Google Scholar 

  12. Ticinesi A, Lauretani F, Nouvenne A, Porro E, Fanelli G, Maggio M, et al. C-reactive protein (CRP) measurement in geriatric patients hospitalized for acute Infection. Eur J Intern Med janv. 2017;37:7–12.

    Article  CAS  Google Scholar 

  13. Nakayama T, Sonoda S, Urano T, Yamada T, Okada M. Monitoring both serum amyloid protein A and C-reactive protein as inflammatory markers in infectious Diseases. Clin Chem. Feb; 1993;39(2):293–7.

    Article  CAS  PubMed  Google Scholar 

  14. Delèvaux I, André M, Colombier M, Albuisson E, Meylheuc F, Bègue RJ, et al. Can procalcitonin measurement help in differentiating between bacterial Infection and other kinds of inflammatory processes? Ann Rheum Dis avr. 2003;62(4):337–40.

    Article  Google Scholar 

  15. Gurwitz JH, Field TS, Avorn J, McCormick D, Jain S, Eckler M. Incidence and preventability of adverse drug events in nursing homes. Am J Med août. 2000;1(2):87–94.

    Article  Google Scholar 

  16. Bass DA, Gonwa TA, Szejda P, Cousart MS, DeChatelet LR, McCall CE. Eosinopenia of Acute Infection. J Clin Invest juin. 1980;65(6):1265–71.

    Article  CAS  Google Scholar 

  17. Gil H, Magy N, Mauny F, Dupond JL. Valeur De l’éosinopénie dans le diagnostic des syndromes inflammatoires: un « vieux » marqueur revisité. Rev Médecine Interne Juill. 2003;24(7):431–5.

    Article  CAS  Google Scholar 

  18. Bouldoires B, Gil H, Soumagne T, Humbert S, Meaux Ruault N, Magy Bertrand N. Proposition d’un score prédictif d’infection bactérienne selon le taux d’éosinophiles: étude observationnelle. Rev Médecine Interne. Jan; 2018;39(1):10–6.

    Article  CAS  Google Scholar 

  19. Davido B, Makhloufi S, Matt M, Calin R, Senard O, Perronne C. Changes in eosinophil count during bacterial Infection: revisiting an old marker to assess the efficacy of antimicrobial therapy. Int J Infect Dis. 2017;61:62–6.

    Article  CAS  PubMed  Google Scholar 

  20. Zhao HM, Qin WQ, Wang PJ, Wen ZM. Eosinopenia is a predictive factor for the severity of acute ischemic Stroke. Neural Regen Res. 2019;14(10):1772.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Outh R, Boutin C, Gueudet P, Suzuki M, Saada M, Aumaître H. Eosinopenia < 100/µL as a marker of active COVID-19: an observational prospective study. J Microbiol Immunol Infect Wei Mian Yu Gan Ran Za Zhi févr. 2021;54(1):61–8.

    Article  CAS  Google Scholar 

  22. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–83.

    Article  CAS  PubMed  Google Scholar 

  23. Michels WM, Grootendorst DC, Verduijn M, Elliott EG, Dekker FW, Krediet RT. Performance of the Cockcroft-Gault, MDRD, and new CKD-EPI formulas in relation to GFR, age, and body size. Clin J Am Soc Nephrol CJASN juin. 2010;5(6):1003–9.

    Article  Google Scholar 

  24. Denutrion diagnosis in. patients > 75 years old, recommandation HAS (in french) [Internet]. Disponible sur: https://www.has-sante.fr/plugins/ModuleXitiKLEE/types/FileDocument/doXiti.jsp?id=p_3297884.

  25. Katz S, Akpom CA. A measure of primary sociobiological functions. Int J Health Serv Plan Adm Eval. 1976;6(3):493–508.

    Article  CAS  Google Scholar 

  26. Folstein M, Anthony JC, Parhad I, Duffy B, Gruenberg EM. The meaning of cognitive impairment in the elderly. J Am Geriatr Soc avr. 1985;33(4):228–35.

    Article  CAS  Google Scholar 

  27. Cunha BA. nov. Pneumonia in the elderly. Clin Microbiol infect off publ eur soc clin Microbiol Infect Dis. 2001;7(11):581–8.

  28. Lin Y, Rong J, Zhang Z. Silent existence of eosinopenia in sepsis: a systematic review and meta-analysis. BMC Infect Dis mai. 2021;24(1):471.

    Article  Google Scholar 

  29. Kaminsky P, Deibener J, Lesesve JF, Humbert JC. [Changes in hemogram parameters in Infections]. Rev Med Interne févr. 2002;23(2):132–6.

    Article  CAS  Google Scholar 

  30. Partouche B, Pepin M, de Farcy PM, Kahn JE, Sawczynski B, Lechowski L, et al. Persistent eosinopenia is associated with in-hospital mortality among older patients: unexpected prognostic value of a revisited biomarker. BMC Geriatr. oct 2021;14(1):557.

  31. Müller L, Di Benedetto S. From aging to long COVID: exploring the convergence of immunosenescence, inflammaging, and autoimmunity. Front Immunol [Internet]. 2023 [cité 21 nov 2023];14. Disponible sur: https://www.frontiersin.org/articles/https://doi.org/10.3389/fimmu.2023.1298004.

  32. Ramirez GA, Yacoub MR, Ripa M, Mannina D, Cariddi A, Saporiti N, et al. Eosinophils from physiology to Disease: a Comprehensive Review. BioMed Res Int. 2018;2018:1–28.

    Article  Google Scholar 

  33. Baumann A, Gönnenwein S, Bischoff SC, Sherman H, Chapnik N, Froy O, et al. The circadian clock is functional in eosinophils and mast cells. Immunol déc. 2013;140(4):465–74.

    Article  CAS  Google Scholar 

  34. Jarad N. Chronic Obstructive Pulmonary Disease (COPD) and old age? Chron Respir Dis. 2011;8(2):143–51.

    Article  PubMed  Google Scholar 

  35. Yang M, Liu X, Hu Q, Li J, Fu S, Chen D, et al. Eosinopenia as a biomarker for antibiotic use in COPD exacerbations: protocol for a retrospective hospital-based cohort study. BMJ Open 20 janv. 2022;12(1):e051939.

    Article  Google Scholar 

  36. Karakonstantis S, Kalemaki D, Tzagkarakis E, Lydakis C. Pitfalls in studies of eosinopenia and neutrophil-to-lymphocyte count ratio. Infect Dis 4 mars. 2018;50(3):163–74.

    Article  Google Scholar 

  37. Jump RLP, Crnich CJ, Mody L, Bradley SF, Nicolle LE, Yoshikawa TT. Infectious Diseases in older adults of Long-Term Care facilities: Update on Approach to diagnosis and management. J Am Geriatr Soc. 2018;66(4):789–803.

    Article  PubMed  PubMed Central  Google Scholar 

  38. Baclet N, Ficheur G, Alfandari S, Ferret L, Senneville E, Chazard E, et al. Explicit definitions of potentially inappropriate prescriptions of antibiotics in older patients: a compilation derived from a systematic review. Int J Antimicrob Agents Nov. 2017;50(5):640–8.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We thank Gérontopôle d’Ile de France for facilitating this study. Sponsor had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.

Funding

This article was supported by a grant from Gérond’if (Gérontopôle d’Ile de France) (N°IDRCB 2020-A00301-38).

Author information

Authors and Affiliations

  1. Service Hospitalo-Universitaire de gériatrie. Assistance Publique-Hôpitaux de Paris, Hôpitaux Universitaires Paris- Saclay, Hôpital Paul-Brousse- Villejuif FR, 12 Avenue Paul Vaillant Couturier, Villejuif, 94800, France

    Léa Mésinèle, Tom Pujol, Nicoletta Brunetti, Marie Neiss, Christophe Trivalle, Cecile Souques, Nadège Houenou-Quenum, Sébastien Verdier, Pauline Simon, Anne-Laure Vetillard, Julie Houdre, Rocco Collarino, Morgane Mary, Magali Guichardon, Emmanuelle Duron & Edouard Baudouin

  2. Département de Gériatrie, Assistance Publique-Hôpitaux de Paris, Hôpital Broca, Paris, France

    Jean-Sébastien Vidal

  3. Université Paris Descartes, INSERM, Paris, France

    Jean-Sébastien Vidal

  4. Department of Internal Medicine, APHP, Ambroise Paré Hospital, Université de Versailles-Saint- Quentin en Yvelines, Yvelines, France

    Jean-Emmanuel Kahn

  5. CESP, Team MOODS, Université Paris-Saclay, UVSQ, Le Kremlin-Bicêtre, France

    Emmanuelle Duron & Edouard Baudouin

Authors
  1. Léa Mésinèle
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Tom Pujol
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Nicoletta Brunetti
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Marie Neiss
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Christophe Trivalle
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Cecile Souques
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Nadège Houenou-Quenum
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Sébastien Verdier
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Pauline Simon
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Anne-Laure Vetillard
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Julie Houdre
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Rocco Collarino
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Morgane Mary
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. Jean-Sébastien Vidal
    View author publications

    You can also search for this author in PubMed Google Scholar

  15. Jean-Emmanuel Kahn
    View author publications

    You can also search for this author in PubMed Google Scholar

  16. Magali Guichardon
    View author publications

    You can also search for this author in PubMed Google Scholar

  17. Emmanuelle Duron
    View author publications

    You can also search for this author in PubMed Google Scholar

  18. Edouard Baudouin
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

All authors have read and approved of the submission of this manuscript. LM, TP, EB, JSV, and ED contributed to the study concept and design.LM, TP, NB, MN, CT, CS, NHQ, SV, PS, ALV, JH, RC, MM, MG, ED, EB contributed to data acquisition. LM, TP, and EB drafted the manuscript. All authors contributed to critical revisions of the manuscript for important intellectual content. EB was responsible for statistical analysis. ED obtained funding. EB, ED, JSV and JEK provided study supervision.

Corresponding author

Correspondence to Edouard Baudouin.

Ethics declarations

Ethics approval and consent to participate

This study was performed in accordance with the Declaration of Helsinki. All participants gave informed consent. This study was approved by an independent ethics committee (Comité de protection des personnes Sud Est V, Grenoble, France: 0-GERO-01, 05/14/2020).

Consent for publication

Not applicable.

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Mésinèle, L., Pujol, T., Brunetti, N. et al. Association between low eosinophil count and acute bacterial infection, a prospective study in hospitalized older adults. BMC Geriatr 23, 852 (2023). https://doi.org/10.1186/s12877-023-04581-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12877-023-04581-y

Keywords

BMC Geriatrics

ISSN: 1471-2318

Contact us